Crossmark

Osimertinib schließt Therapielücke

Crossref DOI link: https://doi.org/10.1007/s15033-025-4160-9

Published Online: 2025-04-25

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schmale, Ine
License Information

Text and Data Mining valid from 2025-04-25

Version of Record valid from 2025-04-25
More Information

Article History

First Online: 25 April 2025

Free to read: This content has been made available to all.